Papers

Papers

  • White paper White Paper: The Costs of Animal Disease

    04/10/2012

    Global analysis and advisory firm Oxford Analytica, supported by a group of independent experts in animal health, were commissioned by IFAH to compare international social and economic impacts of three well-documented animal health diseases: FMD, salmonella and rabies.

    Read more
  • Position paper Animal health products and sustainable agriculture

    02/07/2012

    'Sustainable agriculture' is, in essence, about the production and supply of food in a manner that is economically viable and environmentally responsible.

    Read more
  • Position paper Use of serialisation for veterinary medicinal products

    02/07/2012

    Issue The Animal Health Industry is not in favour of the serialisation of veterinary medicinal products. Background In several countries regulators tend to request a serialisation* of veterinary medicinal products because of identical requirements implemented in the human pharmaceutical sector. It would however be a disproportionate measure for the animal health sector, using an unaffordable approach to tackle close to non-existent problems in the animal health sector. Position The Animal...

    Read more
  • Position paper Risk analysis process: the scientific basis for the regulation of veterinary medicines

    02/07/2012

    Issue In the interests of public health, animal health and animal welfare veterinary medicines are regulated to ensure that only safe (for animals, users, consumers and the environment) and effective products of appropriate quality are placed on the market. This process must be achieved in a proportionate and balanced way to allow society to gain the benefits that these products bring. Background Animal health products are essential for animal welfare and make valuable contributions to society by...

    Read more
  • Position paper The protection of registration data for existing and new veterinary medicinal products

    02/07/2012

    IFAH, the International Federation for Animal Health, supports legislation which provides effective and adequate protection of regulatory data submitted for the market approval of new and existing veterinary medicinal products (i.e. veterinary pharmaceuticals, vaccines and other animal health products) against unfair commercialisation. Introduction The development and bringing to market of a new veterinary medicinal product requires the originator to conduct extensive chemical,...

    Read more